Celltrion Healthcare Logo (CNW Group/Celltrion Healthcare)

Celltrion Awarded up to $626 Million From the Department of Defense to Supply COVID-19 Point-of-Care (POC) Rapid Antigen Test Kits

  • Celltrion wins contract from DLA to supply rapid antigen test kits
  • 12-month supply for as much as USD 626 million to start next month
  • Celltrion becomes first Korean mass supplier of COVID-19 rapid test kits
    after proving quality, supply capabilities, price competitiveness
Business Wire

INCHEON, South Korea -- September 23, 2021

Celltrion (KRX:068270) announced today that the Defense Logistics Agency (DLA)
under the Department of Defense has awarded Celltrion USA, Inc., a subsidiary
company of Celltrion, a procurement contract for its DiaTrust^TM COVID-19 Ag
Rapid Test.

Celltrion USA will make deliveries to approximately 25,000 U.S. CONUS
locations to support military bases, long-term care facilities, community
testing sites, critical infrastructure, and other designated places on a
weekly basis...

Share this post